Top Biotechnology Startups in 2027

Manifold is a leading research cloud built for life sciences. Biomedical research is now about data of increasing scale, modality, velocity, and complexity. It is also inherently collaborative. The old tools aren’t working. Manifold gives researchers a single place to collect, harmonize, and analyze life sciences data, without having to set up compute infrastructure, do complex data integrations and prep, or hire a large software team.

More than 40% of all fresh produce is wasted in the US, which accounts for over $17 billion dollars in lost product annually and contributes more CO2 emissions than all of US transportation combined. Globally, food that is never consumed accounts for 7% of the global freshwater supply and 308MM hectares of land. Our goal is to reduce these drastic numbers by making the produce supply chain smarter. Strella uses proprietary IoT biosensors to monitor and predict produce quality in real time as it travels the supply chain. We reduce food waste and help deliver better quality produce to consumers. Our product is used commercially in high-value decision-making in apple and pear storage. We’re growing the team to improve our product and service higher impact markets.

Eli is a women's health company on a mission to improve lifelong health through continuous hormone monitoring. Hormones impact physical and mental health every day and at every stage of life. Eli offers real-time insights from hormones in saliva that can be tracked continuously over time, unlike traditional testing methods or send-out tests that only provide a single snapshot. With just three simple steps, Eli's at-home technology provides women with personalized hormone profiles to make informed decisions about their health. Eli is filling a data gap to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions. Eli has raised a total of $9 million so women can have the information they need to optimize their overall health from puberty to beyond menopause.

AcuityMD is bringing transparency and efficiency to the medical device market by helping suppliers build stronger and compliant relationships with doctors and other healthcare providers. Our vertical-focused SaaS and data platform helps Medical Device sales, marketing, medical education, and product development teams collaborate around the multi-faceted relationships these companies have with the users of their products.

Biodock is a cutting-edge, seed-stage bio AI startup backed by Andreessen Horowitz and Y Combinator seed blog post (blog.biodock.ai/announcing-seed-round). We are building the future of AI cloud computing for microscopy images, NGS sequencing data, and more. Advances in our technology translate directly to advances in disease understanding and treatment. We give our product for free to academic scientists as part of our mission to accelerate research around the world. Biodock's cloud platform accelerates microscopy analysis, automating months of microscopy analysis and infrastructure to minutes with our end-to-end AI architecture. Scientists enjoy auto-scaling storage, GPU compute, and 30-50% more accurate analysis. We're building an amazing experience to translate microscopy images to therapeutic insights for academic and enterprise scientists. We're a team of engineers/scientists from Stanford, Pinterest, and Facebook (4 strong, plus two contractors), in a beautiful office in Austin, TX. Join us!

Loyal is a consumer-focused dog longevity & genomics company. We help our furry friends live longer, healthier lives. Loyal was internally incubated by Celine Halioua while at The Longevity Fund. Celine was previously a Ph.D. candidate at Oxford in gene therapy economics and holds a BSc in Neuroscience.

At intellia, we are building a full-spectrum, product-driven biotechnology company focused on developing and commercializing potentially curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. our approach to advancing the broad potential of genome editing includes our plans to enhance our crispr system. on the in vivo side, our systemic lipid nanoparticle or lnp-based delivery system, has the potential to unlock treatment of genetic diseases to both selectively knock out disease-causing genes and introduce targeted insertion of a functional gene. we are also focused on engineering t cell therapies to preserve normal cell physiology. ​our approach is designed to improve safety and efficacy by engineering cell therapies​ that are more precise, potent and persistent.

Biosimulation: Use computers to better understand the mechanisms of life. - Web-based simulation interfaces: Make your complex simulations easy to use. - Simulation data management: Organize the results of your simulations. - Custom hardware support: Make use of your hardware infrastructure to execute simulations. Big Data: Structure the information of life. - Clinical, pre-clinical and research data management: Organize your data from clinical, pre-clinical, or research studies. - Experimental data, protocol and workflow management: Use the latest tools to tie data to scientific workflows and digitized protocols. - Semantic data management: Use semantic technologies to enable higher order interpretation and analysis of your data. Visualization and data exploration: Gain insight through beautiful interfaces. - Rich web-based visualization dashboards: Use interactive visualizations of your data over the web. - Visualizing scientific data: Get the right perspective on your data.

Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics. Our team creates practical tools that help patients, clinicians, and researchers better diagnose, treat, and prevent disease. We are striving to construct a more comprehensive picture of health by integrating three key elements: a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class academic research that illuminates new directions, and the pioneering information science that puts all the pieces together.

Intelligent Digital Drug Discovery and Development (ID4) platform, which provides - Crystal Structure Prediction - Computation of Relative Free energies - Solubility predictions - Prediction of Nucleation Conditions for Crystal Structures for biotechnology and pharmaceutical clients